CRVS icon

Corvus Pharmaceuticals
CRVS

Overview Fund Activity

45 hedge funds and large institutions have $267M invested in Corvus Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 7 closing their positions.

Holders
45
Holders Change
–
Holders Change %
0%
% of All Funds
1.2%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
7
Increased
15
Reduced
10
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ACA
1
Avoro Capital Advisors
New York
$4.42M
2
Millennium Management
2
Millennium Management
New York
$1.81M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$3.62M
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$606K
5
State Street
5
State Street
Massachusetts
$890K

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$16.9M
2
Alyeska Investment Group
2
Alyeska Investment Group
Illinois
$0
3
UOC
3
UBS O'Connor
Illinois
$0
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$2.71M
5
Allianz Asset Management
5
Allianz Asset Management
Germany
$1.87M
Name Market Value Shares Shares
Change 		Shares
Change %
Acadian Asset Management
51
Acadian Asset Management
Massachusetts
– – -159 Closed
Barclays
52
Barclays
United Kingdom
$0 21 +21 New
1 2
3